She earned her PhD at the University of Cincinnati (2009) and completed her postdoc fellowship at Cincinnati Children’s Hospital (2016). Her primary research focus is acute myeloid leukemia (AML), where she uses the latest cutting-edge approaches and technologies for developing new model systems and studying the mechanisms of disease development, progression, and responsiveness to therapeutics. Dr. Meyer’s goal is to better understand and leverage the epigenetics and non-coding RNA biology of AML to inform new ways to treat the disease.